The virologist Margarita del Val explained yesterday at the Royal Academy of Sciences (RAC) that the supply of a monoclonal antibody to neonates to prevent the bronchiolitis virus, has caused the pediatric ICUs to be “empty” this year.
The researcher at the Severo Ochoa Center for Molecular Biology (CBM) gave this example of how the pandemic and the Nobel Prize for the creators of the covid vaccine (Katalin Karikó & Drew Weissman) have given a boost to the development of all types of vaccines: “Now there is an explosion of vaccines, companies are betting more on this type of medicine since public health services have decided to invest in them.”
The expert explained that specific vaccines for age groups are now being developed. There are vaccines for people over 65 years of age, such as that for herpes zoster, or for adolescents, such as that for cervical papilloma, and he gave as an example Australia, where the government has proposed to end the transmission of this virus with an ambitious mandatory vaccination plan. for both boys and girls. “It will not be eradicated,” but its incidence will be minimized.
Del Val participated together with Lourdes Ruiz Desviat, also a CBM researcher, in a talk on messenger RNA technologies, deserving of the 2023 Nobel Prize in Medicine for her application to the creation of vaccines against SARS-COV-2.
Lourdes Ruiz stated that RNA vaccines “They have a great future ahead of them” and also several challenges since we need “rapid vaccines, that do not need cold and that can be administered through patches to reach the entire population,” concluded Margarita del Val.
The talk was moderated by the head of the Coronavirus Laboratory at the National Center for Biotechnology (CNB), Luis Enjuanes.
2024-04-10 10:19:24
#Margarita #del #Val #Passive #immunization #emptied #pediatric #ICUs #diariofarma
